Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Facts, Patterns, and Principles in Drug Discovery: Appraising the Rule of 5 with Measured Physicochemical Data
Christopher P. Tinworth, Robert J. Young
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 18, pp. 10091-10108
Closed Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions
Dean G. Brown, Heike J. Wobst
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 5, pp. 2312-2338
Closed Access | Times Cited: 219
Trends in Molecular Properties, Bioavailability, and Permeability across the Bayer Compound Collection
Daniel H. O’Donovan, Claudia De Fusco, Lara Kuhnke, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 4, pp. 2347-2360
Closed Access | Times Cited: 52
Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023
Dana E. Moseson, Tran Trong Bien, Bharathi Karunakaran, et al.
International Journal of Pharmaceutics X (2024) Vol. 7, pp. 100259-100259
Open Access | Times Cited: 33
Peptidomimetic α-Acyloxymethylketone Warheads with Six-Membered Lactam P1 Glutamine Mimic: SARS-CoV-2 3CL Protease Inhibition, Coronavirus Antiviral Activity, and in Vitro Biological Stability
Bing Bai, Alexandr Belovodskiy, Mostofa Abu Hena, et al.
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2905-2925
Closed Access | Times Cited: 94
Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability
Saurabh Verma, Umesh K. Goand, Athar Husain, et al.
Drug Development Research (2021) Vol. 82, Iss. 7, pp. 927-944
Closed Access | Times Cited: 85
Target-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies
Paul D. Leeson, A. Patrícia Bento, Anna Gaulton, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 11, pp. 7210-7230
Open Access | Times Cited: 85
The Time and Place for Nature in Drug Discovery
Robert J. Young, Sabine L. Flitsch, Michael Grigalunas, et al.
JACS Au (2022) Vol. 2, Iss. 11, pp. 2400-2416
Open Access | Times Cited: 67
Lipid-based emulsion drug delivery systems — a comprehensive review
Dhaval Mori, Poonam Vaghela, Kajal S. Patel, et al.
Drug Delivery and Translational Research (2021) Vol. 12, Iss. 7, pp. 1616-1639
Closed Access | Times Cited: 57
Trends in small molecule drug properties: A developability molecule assessment perspective
Prashant Agarwal, James E. Huckle, Jake Newman, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 12, pp. 103366-103366
Closed Access | Times Cited: 51
Property-Based Drug Design Merits a Nobel Prize
Lewis D. Pennington, Matthew J. Hesse, Dennis C. Koester, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 13
Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors
Bing Bai, Elena Arutyunova, Muhammad Bashir Khan, et al.
RSC Medicinal Chemistry (2021) Vol. 12, Iss. 10, pp. 1722-1730
Open Access | Times Cited: 50
Modulation of the H-Bond Basicity of Functional Groups by α-Fluorine-Containing Functions and its Implications for Lipophilicity and Bioisosterism
Yossi Zafrani, Galit Parvari, Dafna Amir, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 8, pp. 4516-4531
Closed Access | Times Cited: 42
Trends in oral small-molecule drug discovery and product development based on product launches before and after the Rule of Five
Sven Stegemann, Chris Moreton, Sami Svanbäck, et al.
Drug Discovery Today (2022) Vol. 28, Iss. 2, pp. 103344-103344
Open Access | Times Cited: 35
Development of Noncovalent Small-Molecule Keap1-Nrf2 Inhibitors by Fragment-Based Drug Discovery
Dilip Narayanan, Kim T. Tran, Jakob S. Pallesen, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 21, pp. 14481-14526
Closed Access | Times Cited: 31
Molecular glues modulate protein functions by inducing protein aggregation: A promising therapeutic strategy of small molecules for disease treatment
Hongyu Wu, Hong Yao, Chen He, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 9, pp. 3548-3566
Open Access | Times Cited: 29
Recent Advances of DprE1 Inhibitors against Mycobacterium tuberculosis: Computational Analysis of Physicochemical and ADMET Properties
Patrícia S. M. Amado, Christopher M. Woodley, Maria L. S. Cristiano, et al.
ACS Omega (2022) Vol. 7, Iss. 45, pp. 40659-40681
Open Access | Times Cited: 27
Basic Nitrogen (BaN) Is a Key Property of Antimalarial Chemical Space
Harsha Valluri, Amritansh Bhanot, Shreeya Shah, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8382-8406
Closed Access | Times Cited: 15
Danshensu inhibits SARS-CoV-2 by targeting its main protease as a specific covalent inhibitor and discovery of bifunctional compounds eliciting antiviral and anti-inflammatory activity
Ruyu Wang, Xuwen Chen, Hongtao Li, et al.
International Journal of Biological Macromolecules (2023) Vol. 257, pp. 128623-128623
Closed Access | Times Cited: 15
Synthesis and Structure–Activity Analysis of Icaritin Derivatives as Potential Tumor Growth Inhibitors of Hepatocellular Carcinoma Cells
Jichong Li, Shuai Shen, Zijian Liu, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 2, pp. 290-306
Closed Access | Times Cited: 14
STOPLIGHT: A Hit Scoring Calculator
James Wellnitz, Holli‐Joi Martin, Mohammad Anwar Hossain, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 11, pp. 4387-4391
Closed Access | Times Cited: 6
Engineering novel scaffolds for specific HDAC11 inhibitors against metabolic diseases exploiting deep learning, virtual screening, and molecular dynamics simulations
Jiali Li, XiaoDie Chen, Rong Liu, et al.
International Journal of Biological Macromolecules (2024) Vol. 262, pp. 129810-129810
Closed Access | Times Cited: 5
Sesquiterpenoids from the sunflower family as potential anti-inflammatory candidates: a review
Cheng Chen, Zheling Feng, Jovana Petrović, et al.
Acta Materia Medica (2023) Vol. 2, Iss. 3
Open Access | Times Cited: 12
Gut Microbiome Integration in Drug Discovery and Development of Small Molecules
Patrick Jimonet, Céline Druart, Stéphanie Blanquet‐Diot, et al.
Drug Metabolism and Disposition (2024) Vol. 52, Iss. 4, pp. 274-287
Open Access | Times Cited: 4
Design and Synthesis of Cyclolipopeptide Mimics of Dysoxylactam A and Evaluation of the Reversing Potencies against P-Glycoprotein-Mediated Multidrug Resistance
Guan‐Zhou Yang, Lei Wang, Kun Gao, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4560-4582
Closed Access | Times Cited: 4
Developing inhaled drugs for respiratory diseases: A medicinal chemistry perspective
Elisa Pasqua, Nicole Hamblin, Christine Edwards, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 1, pp. 134-150
Closed Access | Times Cited: 27
Page 1 - Next Page

Scroll to top